Ann H. Partridge

1. Challenges in ductal carcinoma in situ risk communication and decision‐making
   2012/04/04 by Ann H. Partridge, Joann G. Elmore, Debbie Saslow +2 · 14 citations
   Medicine · Health Professions · Biochemistry, Genetics and Molecular Biology · #Global Cancer Incidence and Screening #Patient-Provider Communication in Healthcare #BRCA gene mutations in cancer
2. Pregnancy After Breast Cancer in Young BRCA Carriers
   2023/12/07 by Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto +97 · 1 voice · 1 citation
   Biochemistry, Genetics and Molecular Biology · Medicine · #BRCA gene mutations in cancer #Cancer Risks and Factors #Reproductive Biology and Fertility
3. “Is it cancer or not?” A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ
   2022/02/22 by Shoshana M. Rosenberg, Jennifer M. Gierisch, Anna Revette +10 · 9 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Global Cancer Incidence and Screening #Breast Cancer Treatment Studies #Cancer survivorship and care
4. Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR trial.
   2025/05/28 by Nadine M. Tung, Nadine Tung, Fengmin Zhao +24 · 1 citation
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #HER2/EGFR in Cancer Research #Lung Cancer Treatments and Mutations